Sonu Bhaskar is an expert in Neurology at South Western Sydney Local Health District (Australia). As of September 2026, ScienceLeadR ranks Sonu Bhaskar in the top 1% of experts worldwide for Cerebrovascular Disorders. Sonu Bhaskar has authored 201 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 726 (community average: 125). How the SLR is computed.

LeadR Profile

726 ScienceLeadR Reputation 726
Network Map

Neurology

Subspecialties: Public Health - Biochemistry - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr Sonu Bhaskar, MD, PhD, PHF, FANA, is an internationally acclaimed neurologist and physician-scientist specialising in vascular neurology and neuroradiology. He has over 200 peer-reviewed publications (H-index of 70 on Google Scholar, with more than 60,000 citations), ranking in the top 0.3% of the most cited research in neurology globally (Stanford/Clarivate Rankings 2025). Dr Bhaskar has delivered over 150 invited talks, including teaching lectures in neurology and global health, health systems leadership courses, and training programmes, and has chaired sessions at major national and international meetings. His publications appear in respected journals such as Nature Aging, The Lancet Neurology, Annals of Clinical and Translational Neurology, BMC Neurology, European Journal of Neuroscience, Annals of the New York Academy of Sciences, and Journal of Clinical Neurology and Neurosurgery. Dr Bhaskar is the founder and director of the Global Health Neurology Lab (Institute), which focuses on addressing disparities in neurological care and promoting health equity worldwide. He leads a multidisciplinary team of over 50 professionals in global health research. He is also the visionary behind the world’s first NSW Brain Clot Bank in Sydney, housed within NSW Health Pathology. The NSW Brain Clot Bank is pioneering transformative research focused on the prevention and treatment of strokes, setting a new benchmark in cerebrovascular health innovation. Dr. Bhaskar has several years of leadership and governance experience in initiating and delivering systems change in senior leadership and executive roles at academic, healthcare, and research organizations, as well as not-for-profit boards and international consortia. Dr Bhaskar leads national and international initiatives on reducing health disparities with a focus on vulnerable populations and under-resourced settings. During the COVID-19 pandemic, Dr Bhaskar led the Pandemic Health System REsilience PROGRAM (REPROGRAM) international consortium (> 150 members from > 25 countries) of international healthcare physicians, researchers, and policymakers formed to champion the safety of healthcare workers, policy development, and advocacy for global pandemic preparedness and action. Dr. Bhaskar is a founding member, chair, and co-manager of the "Global Health and Migration" Community of Practice with the Berlin-based Global Health Hub Germany, championing interdisciplinary collaborations to address health challenges and promote equitable solutions for migrant populations worldwide. He serves on the editorial board of several leading journals, including PLOS One, BMC Neurology, BMC Medical Research Methodology, Frontiers in Stroke, Frontiers in Ageing, and Frontiers in Public Health. Dr Bhaskar has been featured on the Sydney Morning Herald, 9 News, Reuters Health/Medscape, Rotary Down Under, and ABC News-MSN. Currently on sabbatical as Visiting Director at the National Cerebral and Cardiovascular Centre in Osaka, Japan (2023-25), Dr Bhaskar's research and leadership have informed and shaped healthcare policy not only within the Asia-Pacific region but also on a global level. His accolades include the European Academy of Neurology Investigator Award (2019; two-time winner), the Rotary Vocational Excellence Award (2020), election as a Fellow of the American Neurological Association (2022), the Australian Global Talent Award (2023), full membership of Sigma Xi (one of the world's most prestigious research honour societies), the JSPS International Fellowship (2023-25), and the TouchNeurology Future Leader (2025), among others.

Organizations

Career arc: 2023 - 2026

Source: PubMed

National Cerebral and Cardiovascular Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 201

Citations

Citations: 38 630 1st author: 23 Last author: 67 Unique author: 13


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Global and regional progress towards reduced burden of oral conditions between 2019 and 2023: a systematic analysis for the Global Burden of Disease Study 2023.
PMID 42612648 — dental caries, tooth, incidence, neoplasms, tooth, deciduous, public health, global burden of disease, prevalence, cost of illness, mouth, lip
Lancet Public Health20260
Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990-2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023.
PMID 42612647 — nurses, health workforce, pharmacists, public health, global burden of disease, dentists, sex, occupations, cost of illness, retention, psychology, workforce
Lancet Public Health20260
Stillbirths at 22- and 28-weeks' gestation or longer for the states in India: findings from the Global Burden of Disease Study 2023.
PMID 42565145 — pregnancy, mortality, stillbirth, infant mortality, global burden of disease, cost of illness
Lancet Reg Health Southeast Asia20260
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.
PMID 42525403 — myocardial ischemia, heart diseases, cholesterol, ldl, growth, ischemic stroke, stroke, heart, aging, uncertainty, global burden of disease, cost of illness, therapeutics, demography
JAMA Top journal20260
Mapping drivers of life expectancy change in Asia from 1990 to 2023.
PMID 42486974 — mortality, income, life expectancy, risk factors, pandemics
Nature Top journal20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Active not recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map